ResMed Inc. (RMD) — Free Cash Flow Yield
Healthcare
ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
| Metric | Value |
|---|---|
| FCF Yield | 5.1% |
| Healthcare Sector Avg FCF Yield | 4.9% |
| Annual Free Cash Flow | $1.7B |
| Market Cap | $32.4B |
| P/E Ratio | 21.5x |
ResMed Inc.'s FCF yield of 5.1% is above the Healthcare sector average (4.9%).
Frequently Asked Questions
What is ResMed Inc.'s (RMD) free cash flow yield?
ResMed Inc.'s (RMD) free cash flow yield is 5.1%. That is above the Healthcare sector average (4.9%).
Is RMD's free cash flow yield good?
At 5.1%, RMD's free cash flow yield is considered fair — yields above 10% are generally excellent, 7–10% good, 4–7% fair, and below 4% weak, though context varies by sector and growth stage.
How much free cash flow does ResMed Inc. generate?
ResMed Inc. generated $1.7B in free cash flow, against a market cap of $32.4B.
How is free cash flow yield calculated?
Free cash flow yield = (Free Cash Flow ÷ Market Capitalization) × 100%. Free cash flow equals operating cash flow minus capital expenditures.
Data from public filings. Not investment advice. Calculate your own FCF yield →